Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Ann Rheum Dis. 2021 Mar;80(3):e37. doi: 10.1136/annrheumdis-2020-217864. Epub 2020 Jun 5.
No abstract available

Keywords: inflammation; rituximab; scleroderma; systemic.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Pneumonia*
  • Rituximab / therapeutic use
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / drug therapy

Substances

  • Rituximab